CLINICAL_TRIALS
trial_result
· 2011-10-13
Clinical Trial Update: A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA) [Phase 3]
Summary
Phase 3 trial update showing results for omalizumab (Xolair) in subjects with moderate to severe persistent asthma (EXTRA); the study is completed with results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2011-10-13